UA85709C2 - Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии - Google Patents

Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии

Info

Publication number
UA85709C2
UA85709C2 UAA200612183A UAA200612183A UA85709C2 UA 85709 C2 UA85709 C2 UA 85709C2 UA A200612183 A UAA200612183 A UA A200612183A UA A200612183 A UAA200612183 A UA A200612183A UA 85709 C2 UA85709 C2 UA 85709C2
Authority
UA
Ukraine
Prior art keywords
therapeutic use
derivatives production
substituted
pyridoindolone derivatives
сalkyl
Prior art date
Application number
UAA200612183A
Other languages
English (en)
Ukrainian (uk)
Inventor
Бернар Бурри
Пьер Сазелла
Паола Чиапетти
Жан Мари Дерок
Самир Жегам
Иветт Мюно
Камилль-Жорж Вермют
Original Assignee
Санофи Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи Авентис filed Critical Санофи Авентис
Publication of UA85709C2 publication Critical patent/UA85709C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
UAA200612183A 2004-04-21 2005-04-20 Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии UA85709C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0404251A FR2869316B1 (fr) 2004-04-21 2004-04-21 Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
UA85709C2 true UA85709C2 (ru) 2009-02-25

Family

ID=34945552

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200612183A UA85709C2 (ru) 2004-04-21 2005-04-20 Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии

Country Status (31)

Country Link
US (1) US7812165B2 (ru)
EP (1) EP1742947B1 (ru)
JP (1) JP4809830B2 (ru)
KR (1) KR20070002094A (ru)
CN (1) CN100537568C (ru)
AR (1) AR048932A1 (ru)
AT (1) ATE405565T1 (ru)
AU (1) AU2005240816A1 (ru)
BR (1) BRPI0510060A (ru)
CA (1) CA2562561A1 (ru)
CR (1) CR8677A (ru)
DE (1) DE602005009166D1 (ru)
DK (1) DK1742947T3 (ru)
EC (1) ECSP066918A (ru)
ES (1) ES2313371T3 (ru)
FR (1) FR2869316B1 (ru)
HK (1) HK1106223A1 (ru)
IL (1) IL178444A0 (ru)
MA (1) MA28546B1 (ru)
MX (1) MXPA06012127A (ru)
MY (1) MY137599A (ru)
NO (1) NO20065323L (ru)
PL (1) PL1742947T3 (ru)
PT (1) PT1742947E (ru)
RU (1) RU2364595C2 (ru)
TN (1) TNSN06337A1 (ru)
TW (1) TW200538114A (ru)
UA (1) UA85709C2 (ru)
UY (1) UY28864A1 (ru)
WO (1) WO2005108398A1 (ru)
ZA (1) ZA200608646B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
WO1995028493A1 (en) 1994-04-13 1995-10-26 The Rockefeller University Aav-mediated delivery of dna to cells of the nervous system
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
EP1068205A1 (en) 1998-04-02 2001-01-17 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
UY28864A1 (es) 2005-11-30
US7812165B2 (en) 2010-10-12
RU2364595C2 (ru) 2009-08-20
CR8677A (es) 2007-08-28
BRPI0510060A (pt) 2007-10-16
WO2005108398A1 (fr) 2005-11-17
DK1742947T3 (da) 2009-01-05
DE602005009166D1 (de) 2008-10-02
MA28546B1 (fr) 2007-04-03
FR2869316A1 (fr) 2005-10-28
TW200538114A (en) 2005-12-01
CA2562561A1 (fr) 2005-11-17
EP1742947B1 (fr) 2008-08-20
US20070129365A1 (en) 2007-06-07
PT1742947E (pt) 2008-11-25
FR2869316B1 (fr) 2006-06-02
AU2005240816A1 (en) 2005-11-17
AR048932A1 (es) 2006-06-14
KR20070002094A (ko) 2007-01-04
CN100537568C (zh) 2009-09-09
JP4809830B2 (ja) 2011-11-09
MXPA06012127A (es) 2007-01-31
EP1742947A1 (fr) 2007-01-17
PL1742947T3 (pl) 2009-01-30
MY137599A (en) 2009-02-27
ZA200608646B (en) 2008-02-27
RU2006140998A (ru) 2008-05-27
ES2313371T3 (es) 2009-03-01
JP2007533710A (ja) 2007-11-22
HK1106223A1 (en) 2008-03-07
ATE405565T1 (de) 2008-09-15
TNSN06337A1 (en) 2008-02-22
CN1956986A (zh) 2007-05-02
IL178444A0 (en) 2007-02-11
ECSP066918A (es) 2007-01-26
NO20065323L (no) 2006-12-08

Similar Documents

Publication Publication Date Title
TW200732306A (en) Pyrimidine derivatives
TW200833675A (en) Nicotinamide derivatives
MX2007004698A (es) Sintesis asimetrica de dihidrobenzofuranos sustituidos.
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
TW200745034A (en) New compounds
WO2007036532A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
TW200619215A (en) Asymmetric synthesis of dihydrobenzofuran derivatives
TNSN08494A1 (en) Spirocyclic nitriles as protease inhibitors
GEP20125637B (en) Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
WO2008146914A1 (ja) 複素環化合物
TW200728298A (en) Thiophene compounds and thrombopoietin receptor activators
TW200732338A (en) Aromatic compound
MXPA05011962A (es) Oxiarenos substituidos.
MX2010001566A (es) Derivado de aminopirazolamida.
GB0621805D0 (en) Organic compounds
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
WO2009034029A3 (de) 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten
TW200628153A (en) Novel compounds
UA85709C2 (ru) Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии
TW200619201A (en) Process for the preparation of pyrazoles